With its discovery of small molecules that activate RNA methylation, the biotech has broken new ground in epitranscriptomics. This breakthrough positions Chemestmed to advance candidates with the ...
UK biotech MiNA Therapeutics has signed up another big pharma partner for its small activating RNA (saRNA) platform, which upregulates the activity of proteins, with Eli Lilly the latest to get in ...
The snRNA Activating Protein Complex (SNAPc ... the authors identify the small RNA ArcZ targets many capsule genes and a key virulence factor MlaA, inhibiting Klebsiella infection and pathogenesis ...
Ractigen Therapeutics Announces First Patient Dosed in Phase I Clinical Trial for RAG-17 in SOD1-ALS
A leader in small activating RNA (saRNA) drug development, Ractigen Therapeutics is at the forefront of developing saRNA drugs utilizing RNA activation (RNAa) mechanism to up-regulate endogenous ...
LONDON--(BUSINESS WIRE)--MiNA Therapeutics Limited, the pioneer in small activating RNA (RNAa) therapeutics, today presented new pre-clinical data for its lead RNA activation program for the ...
Biologists have shown that the surfaces of plant leaves are coated with a diverse array of RNA molecules. The finding suggests that the RNA present on the leaf surface may play a role in shaping the ...
Ractigen Therapeutics is dedicated to advancing its pipeline, including RAG-17 and RAG-21, while exploring innovative treatments for rare diseases. Through its groundbreaking work in RNA-based drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback